| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | microfilament motor activity | 1.05e-15 | 38 | 33 | 8 | GO:0000146 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.44e-11 | 118 | 33 | 8 | GO:0003774 | |
| GeneOntologyMolecularFunction | actin filament binding | 2.68e-09 | 227 | 33 | 8 | GO:0051015 | |
| GeneOntologyMolecularFunction | calmodulin binding | 2.97e-09 | 230 | 33 | 8 | GO:0005516 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 3.43e-08 | 614 | 33 | 10 | GO:0140657 | |
| GeneOntologyMolecularFunction | actin binding | 8.47e-07 | 479 | 33 | 8 | GO:0003779 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | 5.21e-05 | 1099 | 33 | 9 | GO:0008092 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 7.49e-05 | 441 | 33 | 6 | GO:0016887 | |
| GeneOntologyMolecularFunction | myosin phosphatase activity | 3.70e-04 | 85 | 33 | 3 | GO:0017018 | |
| GeneOntologyMolecularFunction | protein serine/threonine phosphatase activity | 7.66e-04 | 109 | 33 | 3 | GO:0004722 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 1.51e-03 | 775 | 33 | 6 | GO:0017111 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 2.26e-03 | 839 | 33 | 6 | GO:0016462 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 2.28e-03 | 840 | 33 | 6 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 2.28e-03 | 840 | 33 | 6 | GO:0016818 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 2.97e-03 | 49 | 33 | 2 | GO:0140359 | |
| GeneOntologyMolecularFunction | phosphoprotein phosphatase activity | 3.70e-03 | 189 | 33 | 3 | GO:0004721 | |
| GeneOntologyBiologicalProcess | muscle filament sliding | 4.20e-14 | 15 | 32 | 6 | GO:0030049 | |
| GeneOntologyBiologicalProcess | actin-myosin filament sliding | 1.55e-13 | 18 | 32 | 6 | GO:0033275 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 3.85e-08 | 127 | 32 | 6 | GO:0070252 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 1.17e-07 | 153 | 32 | 6 | GO:0030048 | |
| GeneOntologyBiologicalProcess | muscle contraction | 1.31e-07 | 400 | 32 | 8 | GO:0006936 | |
| GeneOntologyBiologicalProcess | muscle system process | 1.39e-06 | 547 | 32 | 8 | GO:0003012 | |
| GeneOntologyBiologicalProcess | ribonucleoside triphosphate metabolic process | 4.89e-06 | 290 | 32 | 6 | GO:0009199 | |
| GeneOntologyBiologicalProcess | nucleoside triphosphate metabolic process | 6.77e-06 | 307 | 32 | 6 | GO:0009141 | |
| GeneOntologyBiologicalProcess | ribonucleotide metabolic process | 1.42e-05 | 533 | 32 | 7 | GO:0009259 | |
| GeneOntologyBiologicalProcess | ribose phosphate metabolic process | 1.55e-05 | 540 | 32 | 7 | GO:0019693 | |
| GeneOntologyBiologicalProcess | ATP metabolic process | 4.42e-05 | 257 | 32 | 5 | GO:0046034 | |
| GeneOntologyBiologicalProcess | actin filament-based process | 5.78e-05 | 912 | 32 | 8 | GO:0030029 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside triphosphate metabolic process | 6.98e-05 | 283 | 32 | 5 | GO:0009205 | |
| GeneOntologyBiologicalProcess | nucleotide metabolic process | 6.98e-05 | 684 | 32 | 7 | GO:0009117 | |
| GeneOntologyBiologicalProcess | skeletal muscle contraction | 7.12e-05 | 52 | 32 | 3 | GO:0003009 | |
| GeneOntologyBiologicalProcess | nucleoside phosphate metabolic process | 7.44e-05 | 691 | 32 | 7 | GO:0006753 | |
| GeneOntologyBiologicalProcess | purine nucleoside triphosphate metabolic process | 7.96e-05 | 291 | 32 | 5 | GO:0009144 | |
| GeneOntologyBiologicalProcess | sarcomere organization | 1.04e-04 | 59 | 32 | 3 | GO:0045214 | |
| GeneOntologyBiologicalProcess | purine ribonucleotide metabolic process | 1.19e-04 | 512 | 32 | 6 | GO:0009150 | |
| GeneOntologyBiologicalProcess | nucleobase-containing small molecule metabolic process | 1.43e-04 | 767 | 32 | 7 | GO:0055086 | |
| GeneOntologyBiologicalProcess | musculoskeletal movement | 1.66e-04 | 69 | 32 | 3 | GO:0050881 | |
| GeneOntologyBiologicalProcess | multicellular organismal movement | 1.96e-04 | 73 | 32 | 3 | GO:0050879 | |
| GeneOntologyBiologicalProcess | myofibril assembly | 3.18e-04 | 86 | 32 | 3 | GO:0030239 | |
| GeneOntologyBiologicalProcess | purine nucleotide metabolic process | 3.32e-04 | 619 | 32 | 6 | GO:0006163 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 3.40e-04 | 217 | 32 | 4 | GO:0006941 | |
| GeneOntologyBiologicalProcess | adult heart development | 3.51e-04 | 18 | 32 | 2 | GO:0007512 | |
| GeneOntologyBiologicalProcess | striated muscle cell development | 3.52e-04 | 89 | 32 | 3 | GO:0055002 | |
| GeneOntologyBiologicalProcess | purine-containing compound metabolic process | 4.38e-04 | 652 | 32 | 6 | GO:0072521 | |
| GeneOntologyCellularComponent | muscle myosin complex | 1.96e-19 | 16 | 33 | 8 | GO:0005859 | |
| GeneOntologyCellularComponent | myosin filament | 1.63e-17 | 25 | 33 | 8 | GO:0032982 | |
| GeneOntologyCellularComponent | myosin II complex | 4.68e-17 | 28 | 33 | 8 | GO:0016460 | |
| GeneOntologyCellularComponent | myosin complex | 3.23e-14 | 59 | 33 | 8 | GO:0016459 | |
| GeneOntologyCellularComponent | myofibril | 7.99e-09 | 273 | 33 | 8 | GO:0030016 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 1.28e-08 | 290 | 33 | 8 | GO:0043292 | |
| GeneOntologyCellularComponent | sarcomere | 1.03e-07 | 249 | 33 | 7 | GO:0030017 | |
| GeneOntologyCellularComponent | actin cytoskeleton | 2.39e-06 | 576 | 33 | 8 | GO:0015629 | |
| GeneOntologyCellularComponent | supramolecular fiber | 6.30e-05 | 1179 | 33 | 9 | GO:0099512 | |
| GeneOntologyCellularComponent | supramolecular polymer | 6.64e-05 | 1187 | 33 | 9 | GO:0099081 | |
| GeneOntologyCellularComponent | A band | 3.05e-03 | 52 | 33 | 2 | GO:0031672 | |
| MousePheno | abnormal skeletal muscle fiber type ratio | 4.78e-05 | 40 | 25 | 3 | MP:0009409 | |
| MousePheno | abnormal heart left ventricle pressure | 5.95e-05 | 43 | 25 | 3 | MP:0010754 | |
| MousePheno | impaired muscle contractility | 1.57e-04 | 297 | 25 | 5 | MP:0000738 | |
| MousePheno | dilated cardiomyopathy | 1.62e-04 | 60 | 25 | 3 | MP:0002795 | |
| MousePheno | abnormal heart ventricle pressure | 1.62e-04 | 60 | 25 | 3 | MP:0008775 | |
| Domain | Myosin_N | 1.83e-19 | 15 | 32 | 8 | IPR004009 | |
| Domain | Myosin_N | 1.83e-19 | 15 | 32 | 8 | PF02736 | |
| Domain | Myosin_tail_1 | 1.24e-18 | 18 | 32 | 8 | PF01576 | |
| Domain | Myosin_tail | 1.24e-18 | 18 | 32 | 8 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 2.14e-18 | 19 | 32 | 8 | IPR027401 | |
| Domain | - | 2.14e-18 | 19 | 32 | 8 | 4.10.270.10 | |
| Domain | MYOSIN_MOTOR | 1.36e-15 | 38 | 32 | 8 | PS51456 | |
| Domain | Myosin_head | 1.36e-15 | 38 | 32 | 8 | PF00063 | |
| Domain | Myosin_head_motor_dom | 1.36e-15 | 38 | 32 | 8 | IPR001609 | |
| Domain | MYSc | 1.36e-15 | 38 | 32 | 8 | SM00242 | |
| Domain | IQ | 8.49e-13 | 81 | 32 | 8 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 2.02e-12 | 90 | 32 | 8 | IPR000048 | |
| Domain | IQ | 2.65e-12 | 93 | 32 | 8 | PS50096 | |
| Domain | IQ | 2.64e-11 | 71 | 32 | 7 | PF00612 | |
| Domain | P-loop_NTPase | 8.51e-08 | 848 | 32 | 11 | IPR027417 | |
| Domain | ABC_A | 1.86e-04 | 12 | 32 | 2 | IPR026082 | |
| Domain | UBA | 2.57e-03 | 44 | 32 | 2 | IPR015940 | |
| Domain | UBA | 2.93e-03 | 47 | 32 | 2 | PS50030 | |
| Domain | ABC_TRANSPORTER_2 | 3.05e-03 | 48 | 32 | 2 | PS50893 | |
| Domain | ABC_tran | 3.05e-03 | 48 | 32 | 2 | PF00005 | |
| Domain | ABC_TRANSPORTER_1 | 3.18e-03 | 49 | 32 | 2 | PS00211 | |
| Domain | ABC_transporter-like | 3.31e-03 | 50 | 32 | 2 | IPR003439 | |
| Domain | UBA-like | 5.37e-03 | 64 | 32 | 2 | IPR009060 | |
| Domain | SAM_1 | 6.04e-03 | 68 | 32 | 2 | PF00536 | |
| Domain | SAM | 9.93e-03 | 88 | 32 | 2 | SM00454 | |
| Domain | SAM_DOMAIN | 1.15e-02 | 95 | 32 | 2 | PS50105 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 1.31e-12 | 70 | 30 | 8 | M12294 | |
| Pathway | KEGG_TIGHT_JUNCTION | 2.35e-10 | 132 | 30 | 8 | M11355 | |
| Pathway | REACTOME_STRIATED_MUSCLE_CONTRACTION | 5.44e-05 | 35 | 30 | 3 | MM15005 | |
| Pathway | REACTOME_STRIATED_MUSCLE_CONTRACTION | 5.92e-05 | 36 | 30 | 3 | M18647 | |
| Pathway | WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY | 6.98e-05 | 38 | 30 | 3 | M39549 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 3.91e-04 | 165 | 30 | 4 | MM15026 | |
| Pubmed | 3.50e-22 | 7 | 33 | 7 | 35210422 | ||
| Pubmed | 3.50e-22 | 7 | 33 | 7 | 16819597 | ||
| Pubmed | 4.51e-19 | 6 | 33 | 6 | 1728586 | ||
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 4.51e-19 | 6 | 33 | 6 | 10077619 | |
| Pubmed | Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development. | 4.51e-19 | 6 | 33 | 6 | 10588881 | |
| Pubmed | 1.26e-17 | 8 | 33 | 6 | 3864153 | ||
| Pubmed | 5.60e-16 | 5 | 33 | 5 | 6196357 | ||
| Pubmed | Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro. | 5.60e-16 | 5 | 33 | 5 | 3829126 | |
| Pubmed | Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development. | 5.60e-16 | 5 | 33 | 5 | 12919077 | |
| Pubmed | Contractile protein gene expression in primary myotubes of embryonic mouse hindlimb muscles. | 7.70e-16 | 13 | 33 | 6 | 8404542 | |
| Pubmed | 1.35e-15 | 14 | 33 | 6 | 27184118 | ||
| Pubmed | ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism. | 1.17e-14 | 7 | 33 | 5 | 29758057 | |
| Pubmed | 3.33e-14 | 22 | 33 | 6 | 24301466 | ||
| Pubmed | Calcineurin is necessary for the maintenance but not embryonic development of slow muscle fibers. | 2.58e-13 | 11 | 33 | 5 | 16024798 | |
| Pubmed | Myosin heavy chain-embryonic regulates skeletal muscle differentiation during mammalian development. | 4.90e-13 | 33 | 33 | 6 | 32094117 | |
| Pubmed | 6.71e-13 | 4 | 33 | 4 | 10388558 | ||
| Pubmed | 6.71e-13 | 4 | 33 | 4 | 20357587 | ||
| Pubmed | 6.71e-13 | 4 | 33 | 4 | 1985022 | ||
| Pubmed | 1.11e-12 | 14 | 33 | 5 | 24938781 | ||
| Pubmed | Six homeoproteins and a Iinc-RNA at the fast MYH locus lock fast myofiber terminal phenotype. | 1.67e-12 | 15 | 33 | 5 | 24852826 | |
| Pubmed | A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. | 2.43e-12 | 16 | 33 | 5 | 19922871 | |
| Pubmed | 3.44e-12 | 17 | 33 | 5 | 16124007 | ||
| Pubmed | HOXA5 plays tissue-specific roles in the developing respiratory system. | 4.11e-12 | 46 | 33 | 6 | 28827394 | |
| Pubmed | 1.76e-11 | 58 | 33 | 6 | 21884692 | ||
| Pubmed | 4.69e-11 | 8 | 33 | 4 | 26993635 | ||
| Pubmed | A Tcf4-positive mesodermal population provides a prepattern for vertebrate limb muscle patterning. | 4.69e-11 | 8 | 33 | 4 | 14667415 | |
| Pubmed | 8.43e-11 | 9 | 33 | 4 | 31960486 | ||
| Pubmed | 9.35e-11 | 31 | 33 | 5 | 21985497 | ||
| Pubmed | The expression of myosin genes in developing skeletal muscle in the mouse embryo. | 1.40e-10 | 10 | 33 | 4 | 2211821 | |
| Pubmed | Acceleration of somitic myogenesis in embryos of myogenin promoter-MRF4 transgenic mice. | 1.40e-10 | 10 | 33 | 4 | 8950513 | |
| Pubmed | 2.21e-10 | 11 | 33 | 4 | 18310078 | ||
| Pubmed | The histone code reader Spin1 controls skeletal muscle development. | 2.21e-10 | 11 | 33 | 4 | 29168801 | |
| Pubmed | 2.21e-10 | 11 | 33 | 4 | 8136524 | ||
| Pubmed | 3.15e-10 | 39 | 33 | 5 | 38690566 | ||
| Pubmed | 4.77e-10 | 13 | 33 | 4 | 8948582 | ||
| Pubmed | 6.68e-10 | 14 | 33 | 4 | 33742095 | ||
| Pubmed | Transition of myosin heavy chain isoforms in human laryngeal abductors following denervation. | 7.78e-10 | 3 | 33 | 3 | 26059207 | |
| Pubmed | Myosin heavy chain gene expression in mouse embryoid bodies. An in vitro developmental study. | 7.78e-10 | 3 | 33 | 3 | 1939265 | |
| Pubmed | Structural and developmental analysis of two linked myosin heavy chain genes. | 7.78e-10 | 3 | 33 | 3 | 1371481 | |
| Pubmed | Mouse embryonic stem cells express the cardiac myosin heavy chain genes during development in vitro. | 7.78e-10 | 3 | 33 | 3 | 1694848 | |
| Pubmed | Identification of three developmentally controlled isoforms of human myosin heavy chains. | 7.78e-10 | 3 | 33 | 3 | 1691980 | |
| Pubmed | 7.78e-10 | 3 | 33 | 3 | 21470888 | ||
| Pubmed | 1.21e-09 | 16 | 33 | 4 | 22090424 | ||
| Pubmed | IKKα and alternative NF-κB regulate PGC-1β to promote oxidative muscle metabolism. | 1.58e-09 | 17 | 33 | 4 | 22351927 | |
| Pubmed | 3.11e-09 | 4 | 33 | 3 | 11023856 | ||
| Pubmed | Smooth muscle myosin light chain kinase expression in cardiac and skeletal muscle. | 3.11e-09 | 4 | 33 | 3 | 11029314 | |
| Pubmed | Modulation of skeletal muscle fiber type by mitogen-activated protein kinase signaling. | 3.11e-09 | 4 | 33 | 3 | 18417546 | |
| Pubmed | ANKS1B MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 LATS1 MYH13 CDK13 ADCY6 | 3.89e-09 | 1442 | 33 | 12 | 35575683 | |
| Pubmed | 4.85e-09 | 22 | 33 | 4 | 37468485 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | 6.54e-09 | 647 | 33 | 9 | 26618866 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | 7.68e-09 | 910 | 33 | 10 | 36736316 | |
| Pubmed | Detection of Gene and Protein Expression in Mouse Embryos and Tissue Sections. | 7.77e-09 | 5 | 33 | 3 | 30737693 | |
| Pubmed | Developmental regulation of myosin gene expression in mouse cardiac muscle. | 7.77e-09 | 5 | 33 | 3 | 2277065 | |
| Pubmed | 7.77e-09 | 5 | 33 | 3 | 6879174 | ||
| Pubmed | Sox6 is required for normal fiber type differentiation of fetal skeletal muscle in mice. | 7.77e-09 | 5 | 33 | 3 | 17584907 | |
| Pubmed | 1.55e-08 | 6 | 33 | 3 | 28381556 | ||
| Pubmed | 1.55e-08 | 6 | 33 | 3 | 20417199 | ||
| Pubmed | A role for Insulin-like growth factor 2 in specification of the fast skeletal muscle fibre. | 1.55e-08 | 6 | 33 | 3 | 17559643 | |
| Pubmed | 2.07e-08 | 31 | 33 | 4 | 30081710 | ||
| Pubmed | 2.37e-08 | 32 | 33 | 4 | 33732701 | ||
| Pubmed | The brain expressed x-linked gene 1 (Bex1) regulates myoblast fusion. | 2.72e-08 | 7 | 33 | 3 | 26586200 | |
| Pubmed | 4.34e-08 | 8 | 33 | 3 | 36200826 | ||
| Pubmed | 4.34e-08 | 8 | 33 | 3 | 33667029 | ||
| Pubmed | Muscle-specific gene expression during myogenesis in the mouse. | 6.51e-08 | 9 | 33 | 3 | 7787235 | |
| Pubmed | 9.30e-08 | 10 | 33 | 3 | 19506036 | ||
| Pubmed | Extracellular matrix protein composition dynamically changes during murine forelimb development. | 1.28e-07 | 11 | 33 | 3 | 38303699 | |
| Pubmed | 1.28e-07 | 11 | 33 | 3 | 30962377 | ||
| Pubmed | 1.28e-07 | 11 | 33 | 3 | 26644518 | ||
| Pubmed | The FgfrL1 receptor is required for development of slow muscle fibers. | 1.28e-07 | 11 | 33 | 3 | 25172430 | |
| Pubmed | Six1 homeoprotein drives myofiber type IIA specialization in soleus muscle. | 1.50e-07 | 50 | 33 | 4 | 27597886 | |
| Pubmed | 1.70e-07 | 12 | 33 | 3 | 8424456 | ||
| Pubmed | Dysregulation of nuclear receptor COUP-TFII impairs skeletal muscle development. | 1.70e-07 | 12 | 33 | 3 | 28600496 | |
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 24876128 | ||
| Pubmed | Failure of Myf5 to support myogenic differentiation without myogenin, MyoD, and MRF4. | 2.21e-07 | 13 | 33 | 3 | 10694423 | |
| Pubmed | Inactivation of the myogenic bHLH gene MRF4 results in up-regulation of myogenin and rib anomalies. | 2.21e-07 | 13 | 33 | 3 | 7797078 | |
| Pubmed | 2.81e-07 | 14 | 33 | 3 | 38327785 | ||
| Pubmed | 2.81e-07 | 14 | 33 | 3 | 21071677 | ||
| Pubmed | Identification of atrogin-1-targeted proteins during the myostatin-induced skeletal muscle wasting. | 3.54e-07 | 155 | 33 | 5 | 22673621 | |
| Pubmed | 4.32e-07 | 16 | 33 | 3 | 16494860 | ||
| Pubmed | 4.32e-07 | 16 | 33 | 3 | 29719249 | ||
| Pubmed | A Critical Role for Estrogen-Related Receptor Signaling in Cardiac Maturation. | 4.64e-07 | 66 | 33 | 4 | 32212902 | |
| Pubmed | Neuron-specific antioxidant OXR1 extends survival of a mouse model of amyotrophic lateral sclerosis. | 6.29e-07 | 18 | 33 | 3 | 25753484 | |
| Pubmed | Defective myogenesis in the absence of the muscle-specific lysine methyltransferase SMYD1. | 6.29e-07 | 18 | 33 | 3 | 26688546 | |
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 21526716 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 18480046 | ||
| Pubmed | Myosin heavy chains IIa and IId are functionally distinct in the mouse. | 8.73e-07 | 2 | 33 | 2 | 9585413 | |
| Pubmed | Murine pulmonary myocardium: developmental analysis of cardiac gene expression. | 8.73e-07 | 2 | 33 | 2 | 7919499 | |
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 23111184 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 25701119 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 28236635 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 34384224 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 2726733 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 24218452 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 16575183 | ||
| Pubmed | Human cardiac myosin heavy chain gene mapped within chromosome region 14q11.2----q13. | 8.73e-07 | 2 | 33 | 2 | 2494889 | |
| Pubmed | Human cardiac myosin heavy chain genes and their linkage in the genome. | 8.73e-07 | 2 | 33 | 2 | 3037493 | |
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 21778428 | ||
| Pubmed | Structural organization of the human cardiac alpha-myosin heavy chain gene (MYH6). | 8.73e-07 | 2 | 33 | 2 | 8307559 | |
| Pubmed | Five skeletal myosin heavy chain genes are organized as a multigene complex in the human genome. | 8.73e-07 | 2 | 33 | 2 | 8518795 | |
| Pubmed | Type IIx myosin heavy chain transcripts are expressed in type IIb fibers of human skeletal muscle. | 8.73e-07 | 2 | 33 | 2 | 7545970 | |
| Interaction | STK3 interactions | 3.79e-12 | 181 | 30 | 9 | int:STK3 | |
| Interaction | PRKAG2 interactions | 6.94e-12 | 68 | 30 | 7 | int:PRKAG2 | |
| Interaction | RSPH6A interactions | 8.35e-12 | 34 | 30 | 6 | int:RSPH6A | |
| Interaction | LATS1 interactions | 1.78e-11 | 440 | 30 | 11 | int:LATS1 | |
| Interaction | ASAH2 interactions | 5.97e-11 | 6 | 30 | 4 | int:ASAH2 | |
| Interaction | STK4 interactions | 6.35e-11 | 159 | 30 | 8 | int:STK4 | |
| Interaction | MYH8 interactions | 1.24e-10 | 52 | 30 | 6 | int:MYH8 | |
| Interaction | LZTR1 interactions | 2.33e-10 | 111 | 30 | 7 | int:LZTR1 | |
| Interaction | CDK3 interactions | 2.81e-10 | 114 | 30 | 7 | int:CDK3 | |
| Interaction | TSPAN33 interactions | 4.97e-10 | 65 | 30 | 6 | int:TSPAN33 | |
| Interaction | TMEM260 interactions | 2.83e-09 | 13 | 30 | 4 | int:TMEM260 | |
| Interaction | MYH6 interactions | 4.75e-09 | 94 | 30 | 6 | int:MYH6 | |
| Interaction | ACTN2 interactions | 4.84e-09 | 171 | 30 | 7 | int:ACTN2 | |
| Interaction | HSPB8 interactions | 5.04e-09 | 172 | 30 | 7 | int:HSPB8 | |
| Interaction | ABTB2 interactions | 7.34e-09 | 101 | 30 | 6 | int:ABTB2 | |
| Interaction | MYH3 interactions | 1.27e-08 | 52 | 30 | 5 | int:MYH3 | |
| Interaction | SLC39A3 interactions | 5.82e-08 | 70 | 30 | 5 | int:SLC39A3 | |
| Interaction | BCAP31 interactions | 7.18e-08 | 554 | 30 | 9 | int:BCAP31 | |
| Interaction | MYH4 interactions | 7.21e-08 | 73 | 30 | 5 | int:MYH4 | |
| Interaction | SBDS interactions | 2.40e-07 | 181 | 30 | 6 | int:SBDS | |
| Interaction | ZSCAN5A interactions | 2.84e-07 | 38 | 30 | 4 | int:ZSCAN5A | |
| Interaction | MYH7 interactions | 3.69e-07 | 101 | 30 | 5 | int:MYH7 | |
| Interaction | AURKC interactions | 4.73e-07 | 43 | 30 | 4 | int:AURKC | |
| Interaction | MYH13 interactions | 7.42e-07 | 48 | 30 | 4 | int:MYH13 | |
| Interaction | TPM1 interactions | 2.13e-06 | 263 | 30 | 6 | int:TPM1 | |
| Interaction | KRT40 interactions | 2.71e-06 | 434 | 30 | 7 | int:KRT40 | |
| Interaction | LACTB2 interactions | 6.44e-06 | 82 | 30 | 4 | int:LACTB2 | |
| Interaction | FKBP6 interactions | 7.78e-06 | 86 | 30 | 4 | int:FKBP6 | |
| Interaction | CCDC69 interactions | 1.18e-05 | 30 | 30 | 3 | int:CCDC69 | |
| Interaction | AKAP17A interactions | 1.36e-05 | 99 | 30 | 4 | int:AKAP17A | |
| Interaction | TLE3 interactions | 1.65e-05 | 376 | 30 | 6 | int:TLE3 | |
| Interaction | LHPP interactions | 2.24e-05 | 37 | 30 | 3 | int:LHPP | |
| Interaction | NTHL1 interactions | 4.62e-05 | 47 | 30 | 3 | int:NTHL1 | |
| Interaction | SIX1 interactions | 5.24e-05 | 49 | 30 | 3 | int:SIX1 | |
| Interaction | TNNI1 interactions | 7.01e-05 | 54 | 30 | 3 | int:TNNI1 | |
| Interaction | CFAP141 interactions | 7.41e-05 | 55 | 30 | 3 | int:CFAP141 | |
| Interaction | TRPM2 interactions | 1.17e-04 | 11 | 30 | 2 | int:TRPM2 | |
| Interaction | HDAC1 interactions | 1.61e-04 | 1108 | 30 | 8 | int:HDAC1 | |
| Interaction | MECOM interactions | 1.70e-04 | 358 | 30 | 5 | int:MECOM | |
| Interaction | PRKACB interactions | 1.84e-04 | 193 | 30 | 4 | int:PRKACB | |
| Interaction | APOA1 interactions | 1.84e-04 | 193 | 30 | 4 | int:APOA1 | |
| Interaction | NEURL2 interactions | 1.93e-04 | 14 | 30 | 2 | int:NEURL2 | |
| Interaction | MYH1 interactions | 1.94e-04 | 76 | 30 | 3 | int:MYH1 | |
| Interaction | CFTR interactions | 2.11e-04 | 1480 | 30 | 9 | int:CFTR | |
| Interaction | FBXO32 interactions | 2.41e-04 | 386 | 30 | 5 | int:FBXO32 | |
| Interaction | TPM2 interactions | 2.49e-04 | 209 | 30 | 4 | int:TPM2 | |
| Interaction | WWOX interactions | 2.78e-04 | 627 | 30 | 6 | int:WWOX | |
| Interaction | SHD interactions | 3.23e-04 | 18 | 30 | 2 | int:SHD | |
| Interaction | SVIL interactions | 3.77e-04 | 233 | 30 | 4 | int:SVIL | |
| Interaction | EDRF1 interactions | 4.24e-04 | 99 | 30 | 3 | int:EDRF1 | |
| Interaction | HIF1A interactions | 4.45e-04 | 441 | 30 | 5 | int:HIF1A | |
| Interaction | KRT8 interactions | 4.45e-04 | 441 | 30 | 5 | int:KRT8 | |
| Interaction | EFNA1 interactions | 4.76e-04 | 103 | 30 | 3 | int:EFNA1 | |
| Interaction | LOXL4 interactions | 4.90e-04 | 104 | 30 | 3 | int:LOXL4 | |
| Interaction | ACTN3 interactions | 5.62e-04 | 109 | 30 | 3 | int:ACTN3 | |
| Interaction | AGRN interactions | 6.29e-04 | 267 | 30 | 4 | int:AGRN | |
| Interaction | C3orf18 interactions | 6.57e-04 | 115 | 30 | 3 | int:C3orf18 | |
| Interaction | TAF6L interactions | 6.57e-04 | 115 | 30 | 3 | int:TAF6L | |
| Interaction | DMAC2L interactions | 7.35e-04 | 27 | 30 | 2 | int:DMAC2L | |
| Interaction | SYT3 interactions | 7.35e-04 | 27 | 30 | 2 | int:SYT3 | |
| Interaction | THYN1 interactions | 7.35e-04 | 27 | 30 | 2 | int:THYN1 | |
| Interaction | SAMD9 interactions | 7.90e-04 | 28 | 30 | 2 | int:SAMD9 | |
| Interaction | PTRH1 interactions | 7.90e-04 | 28 | 30 | 2 | int:PTRH1 | |
| Interaction | ERP29 interactions | 8.18e-04 | 124 | 30 | 3 | int:ERP29 | |
| Interaction | MCM2 interactions | 8.59e-04 | 1081 | 30 | 7 | int:MCM2 | |
| Interaction | ERP27 interactions | 9.08e-04 | 30 | 30 | 2 | int:ERP27 | |
| Interaction | MYOM2 interactions | 9.70e-04 | 31 | 30 | 2 | int:MYOM2 | |
| Interaction | MYOM1 interactions | 9.70e-04 | 31 | 30 | 2 | int:MYOM1 | |
| Interaction | MYL2 interactions | 9.70e-04 | 31 | 30 | 2 | int:MYL2 | |
| Interaction | CDCA8 interactions | 1.00e-03 | 133 | 30 | 3 | int:CDCA8 | |
| Interaction | C3orf52 interactions | 1.03e-03 | 305 | 30 | 4 | int:C3orf52 | |
| Interaction | YWHAQ interactions | 1.05e-03 | 1118 | 30 | 7 | int:YWHAQ | |
| Interaction | ZNF385C interactions | 1.10e-03 | 33 | 30 | 2 | int:ZNF385C | |
| Interaction | ROGDI interactions | 1.10e-03 | 33 | 30 | 2 | int:ROGDI | |
| Cytoband | 17p13.1 | 2.31e-08 | 118 | 33 | 5 | 17p13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p13 | 1.64e-07 | 346 | 33 | 6 | chr17p13 | |
| Cytoband | 17q24.3 | 6.77e-05 | 17 | 33 | 2 | 17q24.3 | |
| Cytoband | 1p33 | 2.94e-04 | 35 | 33 | 2 | 1p33 | |
| Cytoband | 14q12 | 7.27e-04 | 55 | 33 | 2 | 14q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p33 | 8.93e-04 | 61 | 33 | 2 | chr1p33 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q24 | 2.28e-03 | 98 | 33 | 2 | chr17q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q23 | 1.09e-02 | 220 | 33 | 2 | chr11q23 | |
| GeneFamily | Myosin heavy chains | 5.02e-20 | 15 | 27 | 8 | 1098 | |
| GeneFamily | ATP binding cassette subfamily A | 1.93e-04 | 14 | 27 | 2 | 805 | |
| GeneFamily | Cytochrome P450 family 4 | 1.31e-03 | 36 | 27 | 2 | 1003 | |
| GeneFamily | Sterile alpha motif domain containing | 7.60e-03 | 88 | 27 | 2 | 760 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 9.94e-09 | 20 | 33 | 4 | M1123 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 1.23e-08 | 21 | 33 | 4 | MM1102 | |
| Coexpression | HALLMARK_MYOGENESIS | 1.71e-07 | 200 | 33 | 6 | M5909 | |
| Coexpression | EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION | 3.03e-05 | 48 | 33 | 3 | M16123 | |
| Coexpression | DESCARTES_FETAL_EYE_SKELETAL_MUSCLE_CELLS | 6.03e-05 | 170 | 33 | 4 | M40176 | |
| Coexpression | DESCARTES_MAIN_FETAL_SKELETAL_MUSCLE_CELLS | 1.01e-04 | 194 | 33 | 4 | M40093 | |
| Coexpression | AFFAR_YY1_TARGETS_UP | 1.11e-04 | 199 | 33 | 4 | M1466 | |
| Coexpression | AFFAR_YY1_TARGETS_UP | 1.55e-04 | 217 | 33 | 4 | MM1156 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#3_top-relative-expression-ranked_200 | 2.69e-05 | 6 | 29 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_200_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.80e-05 | 48 | 29 | 3 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_1000_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#4_top-relative-expression-ranked_100 | 5.02e-05 | 8 | 29 | 2 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_100_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_top-relative-expression-ranked_1000 | 5.78e-05 | 761 | 29 | 7 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_1000 | 6.33e-05 | 772 | 29 | 7 | gudmap_developingLowerUrinaryTract_P1_bladder_1000_J | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#5_top-relative-expression-ranked_1000 | 6.52e-05 | 161 | 29 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_J_1000_k5 | |
| CoexpressionAtlas | skeletal muscle | 6.65e-05 | 320 | 29 | 5 | skeletal muscle | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#3_top-relative-expression-ranked_500 | 1.39e-04 | 13 | 29 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_500 | 1.64e-04 | 388 | 29 | 5 | gudmap_developingLowerUrinaryTract_P1_bladder_500_J | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_top-relative-expression-ranked_100 | 1.75e-04 | 80 | 29 | 3 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_100 | 2.17e-04 | 86 | 29 | 3 | gudmap_developingLowerUrinaryTract_P1_bladder_100_J | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_M-2fold-vs-F_top305_305 | 4.47e-04 | 266 | 29 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_250_M-vs-F-2X | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_top-relative-expression-ranked_1000 | 5.33e-04 | 774 | 29 | 6 | gudmap_developingLowerUrinaryTract_P1_ureter_1000 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7-Tac2-Excitatory_Neuron.Slc17a7.Tac2.Syt15_(Medial_habenula)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.94e-09 | 77 | 33 | 5 | 7f624e9262bd0dc2ac4176f43c91a4bc0f521fe5 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.65e-09 | 186 | 33 | 6 | bdc87e4631a8ea73e262e541aa84a28f24c94b00 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.30e-07 | 62 | 33 | 4 | a20620a8869721ea62984c2022ee1b484b455824 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.30e-07 | 62 | 33 | 4 | ee694c06bcd924b4ddf744178ba3a99e04eed51b | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Grp_(Neuron.Slc17a6.Grp)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.57e-07 | 65 | 33 | 4 | b7bc23af54d6d2f7afd584f4df42c24d7c49e344 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Grp_(Neuron.Slc17a6.Grp)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.57e-07 | 65 | 33 | 4 | 3b3630253f5713c4a688c74c4ea0f98c1fe42594 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.22e-07 | 182 | 33 | 5 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Ptgdr|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.18e-06 | 125 | 33 | 4 | d05556ea185c15815a4f8643f1c01185badbeece | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Ptgdr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.83e-06 | 144 | 33 | 4 | 71107275767a0728541a3695715c44874b3e5efc | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Glra3|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.16e-06 | 147 | 33 | 4 | 50e86860a94be103092c40e39a172eac92372f0d | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Fibin|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.40e-06 | 157 | 33 | 4 | 741d79c10cb87fa7f14080c6fccb1553c3a20bad | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Glra3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.82e-06 | 160 | 33 | 4 | 0bfdaf979e6f128cba2928ce16bca4d3deff8ac9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.41e-06 | 164 | 33 | 4 | 382e42701779d12a7948690b3be72d06dd75c8b4 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.39e-06 | 170 | 33 | 4 | 8ab67e2b6e30fdf9e9a2c02e31d4df34e751a3ed | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.03e-05 | 185 | 33 | 4 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.10e-05 | 188 | 33 | 4 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(Neuron.Gad1Gad2.Sst-Nr2f2)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.32e-05 | 62 | 33 | 3 | 9db88da996b9977f5a89afe505cd55e7b5324bc9 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(Neuron.Gad1Gad2.Sst-Nr2f2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.32e-05 | 62 | 33 | 3 | 461d280a1b955033186cfc326f9ace85b4a53c54 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Mesenchymal-Mesoderm|3m / Sample Type, Dataset, Time_group, and Cell type. | 1.40e-05 | 200 | 33 | 4 | 538ae964db58c4acafe93f735b3e03fc08fdaac6 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Bcl11b-Inhibitory_Gad1Gad2_Id2.Bcl11b_(Interneuron,_Neurogliaform2)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.74e-05 | 68 | 33 | 3 | cfd75c373e10b3761666ccd445ba74755efeb95f | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Bcl11b|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.74e-05 | 68 | 33 | 3 | c25fb921dc83eecdc337353894829ae6b5192353 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Bcl11b-Inhibitory_Gad1Gad2_Id2.Bcl11b_(Interneuron,_Neurogliaform2)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.74e-05 | 68 | 33 | 3 | 712f5f4d3a1e0c0db1a340332876206b93bdac31 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Etv1_|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.06e-05 | 97 | 33 | 3 | f3c3fb260954f594a9ab8e1ac9a01115767cbc7a | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_B3-4|TCGA-Thymus / Sample_Type by Project: Shred V9 | 7.35e-05 | 110 | 33 | 3 | 56e93e8d0d6232ab9090f685e5e4803ef79b2567 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.97e-05 | 113 | 33 | 3 | 6f270b7e59c18243e876311df721e948ce21e850 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Myh4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.18e-04 | 129 | 33 | 3 | f83187c0bb06528127b8d2d56674ab1946846951 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Esm1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.23e-04 | 131 | 33 | 3 | 3cb4b272e28ee9bad6d874f64a7aae18352a6cfb | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Etv1_|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.77e-04 | 148 | 33 | 3 | 4d43efee96a6493abd78e9ca41aab73db0c80626 | |
| ToppCell | COVID-19-Heart-CM_5_(RYR2-)|Heart / Disease (COVID-19 only), tissue and cell type | 2.03e-04 | 155 | 33 | 3 | d7e26696fd9c0a759524f331243db43059b33ed9 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7-Tac2|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.23e-04 | 160 | 33 | 3 | fe5fb0e7a79862f63529721f0a82f4f6d231d3ca | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.23e-04 | 160 | 33 | 3 | 7d34159363d274019e14549d1186c629ce990691 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.27e-04 | 161 | 33 | 3 | dccb61d5e17a8f1c6d1fc146ee389f567659a0f0 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2-Exc_L5-6_FEZF2_CABP7|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.27e-04 | 161 | 33 | 3 | a232401010fe2f100dce585899b66f767c208d9d | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.31e-04 | 162 | 33 | 3 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.52e-04 | 167 | 33 | 3 | d78356bf0c473816dbabaee51984940bd822f84e | |
| ToppCell | P15-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.52e-04 | 167 | 33 | 3 | 5c3d0763f73628c71c71f9883556bb4f1639f3cc | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.57e-04 | 168 | 33 | 3 | 8459d0a1bf6d4b5c83001097331f8b78fceb9305 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.57e-04 | 168 | 33 | 3 | a1755afa2cc50960ba60e07d84d61be429cdea72 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_TBC1D26|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.61e-04 | 169 | 33 | 3 | 6e132fdd73b3a9c702eccf5a1a620ec6384b556e | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 2.61e-04 | 169 | 33 | 3 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.80e-04 | 173 | 33 | 3 | 0c74bdb40e635d906fd180412c23bf7fed61621e | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.85e-04 | 174 | 33 | 3 | 3503c7dec498597f76a86dbd5e4bb2311e743bde | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-skeletal_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-04 | 174 | 33 | 3 | 4a6e04b4f12b87c15fa1409989cbe32c43736369 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-04 | 174 | 33 | 3 | ecdff386d7f0bc57c170a2c1f4deae5ba7e431b5 | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-04 | 176 | 33 | 3 | 5201f003192c033655ba47f0faf8c47a96eae03d | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-04 | 178 | 33 | 3 | d3cbdec9d75f076e565baca05ede292cca7758a4 | |
| ToppCell | droplet-Lung-30m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.04e-04 | 178 | 33 | 3 | 82f78ea1ea3ff3e2347cd8bc2f06e2a10e96f220 | |
| ToppCell | droplet-Lung-30m-Epithelial-alveolar_epithelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.04e-04 | 178 | 33 | 3 | 76e71fff99cf64302e2e3c0d66dd8ba0ff13624e | |
| ToppCell | droplet-Lung-30m-Epithelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.04e-04 | 178 | 33 | 3 | 5442bc52b8e902da1383f44d97a9f95e471a8d4d | |
| ToppCell | droplet-Lung-30m-Epithelial-alveolar_epithelial-type_II_pneumocyte|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.04e-04 | 178 | 33 | 3 | 523b286ebe0359c7f1902f28cbd71f452626fc0d | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.09e-04 | 179 | 33 | 3 | 4135f9e8cd8494cbc189e5210dded84659643fb8 | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-04 | 181 | 33 | 3 | cadb18fc73031eb9f779599e15cd7861337fee78 | |
| ToppCell | RA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 3.20e-04 | 181 | 33 | 3 | 2b6ddeb53a79a658e2ba78527ff48c155b20daa6 | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-04 | 181 | 33 | 3 | 85bec4d3f255f4c61c790325eeb50ad38f709ef2 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-skeletal_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-04 | 182 | 33 | 3 | edfc598b7199ca1d8a399b264ab863c299b1eede | |
| ToppCell | droplet-Lung-LUNG-1m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-04 | 182 | 33 | 3 | c1e0be27064e14043b78ae501b02d4e9542267a3 | |
| ToppCell | droplet-Lung-LUNG-1m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-04 | 182 | 33 | 3 | 3c9b4869d357884ae4bcd22a9872faf83a5cfc6d | |
| ToppCell | droplet-Lung-1m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.35e-04 | 184 | 33 | 3 | 24cbe9f2461ea920954e44bf3b2c2a6a5d4debfb | |
| ToppCell | droplet-Lung-1m-Epithelial-alveolar_epithelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.35e-04 | 184 | 33 | 3 | 86c1551c4f7c7d0c35c14852b01b1e602fa5092a | |
| ToppCell | droplet-Lung-1m-Epithelial-alveolar_epithelial-type_II_pneumocyte|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.35e-04 | 184 | 33 | 3 | 98079fd048a63b51bbdf3833b6f15bf0ae99ea90 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.52e-04 | 187 | 33 | 3 | f124d2c699b717b7c02a1a70493f515b83dc2f4c | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.57e-04 | 188 | 33 | 3 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.57e-04 | 188 | 33 | 3 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.57e-04 | 188 | 33 | 3 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | droplet-Lung-nan-18m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-04 | 189 | 33 | 3 | e5325f1c7430b574947f8ee67e425455b60dc518 | |
| ToppCell | droplet-Lung-nan-18m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-04 | 189 | 33 | 3 | ca657353f2b649530809c0bc057e448adc511ec1 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.63e-04 | 189 | 33 | 3 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 3.68e-04 | 190 | 33 | 3 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | droplet-Lung-18m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.68e-04 | 190 | 33 | 3 | a51405f8466fc6d4087873137472619b2e84c1da | |
| ToppCell | droplet-Lung-nan-18m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-04 | 190 | 33 | 3 | b057bea6e55cef872290893b6e439bbcdcee2f2e | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-04 | 190 | 33 | 3 | aaf5f1c1ff7b1454f4e5dacfeb48e1c3627e3372 | |
| ToppCell | droplet-Lung-18m-Epithelial-alveolar_epithelial-type_II_pneumocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.68e-04 | 190 | 33 | 3 | 059beca1c92181b8ba4dcd6fc71ff7530d83d0de | |
| ToppCell | COVID-19-Heart-Mito_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.68e-04 | 190 | 33 | 3 | ea74e0e38bcaba125b48c88331e9ba09228d3178 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-04 | 190 | 33 | 3 | a20123d5c6cb8c2f0dfd99bbfdb571a73c36234d | |
| ToppCell | droplet-Lung-18m-Epithelial-alveolar_epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.74e-04 | 191 | 33 | 3 | caed913e7ede9f8ae3af273d1ecf375de6c5e813 | |
| ToppCell | droplet-Lung-18m-Epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.74e-04 | 191 | 33 | 3 | 1b59f1cad6c1a6a5938afa9195164918e3ff4e86 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 3.74e-04 | 191 | 33 | 3 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | droplet-Lung-3m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.80e-04 | 192 | 33 | 3 | 13e4b17d7a592604140777aca235f795df6b3f91 | |
| ToppCell | droplet-Lung-3m-Epithelial-alveolar_epithelial-type_II_pneumocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.80e-04 | 192 | 33 | 3 | 6244541688f85917018a057aa0b3e5972934dfbc | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 3.80e-04 | 192 | 33 | 3 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 3.80e-04 | 192 | 33 | 3 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | droplet-Lung-3m-Epithelial-alveolar_epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.80e-04 | 192 | 33 | 3 | f51b3fd962263920a6cae783ca7af13f5eb7aaa3 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 3.92e-04 | 194 | 33 | 3 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-8|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 3.92e-04 | 194 | 33 | 3 | 55b97095a7a17a312c616703d291738a0f806339 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 3.97e-04 | 195 | 33 | 3 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.97e-04 | 195 | 33 | 3 | a38d9dc6192aea673d96fda6b25e81223fda3abf | |
| ToppCell | COVID-19-Heart-Mito_CM|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.09e-04 | 197 | 33 | 3 | 44e49943d62bfe622b40ad0460093d31540544df | |
| ToppCell | COVID-19-Heart-Mito_CM|Heart / Disease (COVID-19 only), tissue and cell type | 4.16e-04 | 198 | 33 | 3 | b6cd439863d17209b86dc50ae51282dc1725955d | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.22e-04 | 199 | 33 | 3 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-dn_T|COVID-19_Mild / Disease, condition lineage and cell class | 4.22e-04 | 199 | 33 | 3 | f307d4887b28cf60a591439e278fd668409cb104 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Mesoderm|6m / Sample Type, Dataset, Time_group, and Cell type. | 4.28e-04 | 200 | 33 | 3 | 0f6851baf0cf2a8b0c95a7a585c4407c330c5f6c | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Sla_(Layer6a)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.76e-04 | 52 | 33 | 2 | 14971277db09343d668e4f5a82ca2b6a92326251 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Sla_(Layer6a)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.76e-04 | 52 | 33 | 2 | c134eb63bd1969af2af7f8de5989e19063533865 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L4-L4_IT_VISp_Rspo1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.02e-04 | 53 | 33 | 2 | c8af66760dac32cdbc0f17d1c004596c847f16f6 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.02e-04 | 53 | 33 | 2 | d55030028f9ac970afb343ef6e1c41ab4bb2ae53 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Sphkap-Excitatory_Neuron.Gad1Gad2.Sphkap-Cpne4_(Basomedial_amygdaloid_nucleus_(BMA))-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 7.29e-04 | 54 | 33 | 2 | 79f804e73f859c0e8192d9e9e6ee2282f7f1691b | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Efna5_(Deep_layer_pyramidal_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 7.29e-04 | 54 | 33 | 2 | 13431c23a110070a11de41773233a8d6583d902c | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Efna5_(Deep_layer_pyramidal_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 7.29e-04 | 54 | 33 | 2 | cd64ee5c47df5dba0cea954cb115a8de0efb55d1 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Sphkap-Excitatory_Neuron.Gad1Gad2.Sphkap-Cpne4_(Basomedial_amygdaloid_nucleus_(BMA))|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 7.29e-04 | 54 | 33 | 2 | 7670a6eb185ae0d8c3c0cb17f8eaa9970355187b | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Grm1-Inhibitory_Neuron.Gad1Gad2_Sst.Grm1_(Interneuron,_OLM3_(CA1_enriched?))|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.56e-04 | 55 | 33 | 2 | a55d3edca2dd9ca7a703b2b3a5941b30b5f0a6df | |
| Drug | fast white | 8.86e-16 | 42 | 33 | 8 | CID000024008 | |
| Drug | formycin triphosphate | 4.74e-15 | 51 | 33 | 8 | CID000122274 | |
| Drug | purealin | 1.42e-14 | 58 | 33 | 8 | CID006419303 | |
| Drug | nocodazole | ANKS1B RAF1 MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 LATS1 MYH13 CDK13 ITPR3 | 4.99e-14 | 477 | 33 | 13 | CID000004122 |
| Drug | clenbuterol | 3.75e-13 | 142 | 33 | 9 | CID000002783 | |
| Drug | SM-2 | 4.20e-13 | 87 | 33 | 8 | CID000486033 | |
| Drug | candesartan cilexetil | 4.54e-13 | 145 | 33 | 9 | CID000002540 | |
| Drug | carvedilol | 1.18e-12 | 161 | 33 | 9 | CID000002585 | |
| Drug | S-(-)-Etomoxir | 1.32e-12 | 100 | 33 | 8 | CID000060765 | |
| Drug | verapamil | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH13 ABCA6 ABCA5 ADCY6 ITPR3 | 2.03e-12 | 490 | 33 | 12 | CID000002520 |
| Drug | blebbistatin | 4.44e-12 | 116 | 33 | 8 | CID003476986 | |
| Drug | B0683 | 4.76e-12 | 117 | 33 | 8 | CID006398969 | |
| Drug | oxovanadium | 5.85e-12 | 120 | 33 | 8 | CID000024411 | |
| Drug | 2bq7 | 7.14e-12 | 123 | 33 | 8 | CID006540267 | |
| Drug | AC1L1IZ2 | 1.10e-11 | 304 | 33 | 10 | CID000004795 | |
| Drug | AC1LADJ6 | 1.12e-11 | 130 | 33 | 8 | CID000486032 | |
| Drug | AC1NRBPQ | 1.71e-11 | 137 | 33 | 8 | CID005288569 | |
| Drug | AC1N9ZZC | 3.37e-11 | 149 | 33 | 8 | CID004369374 | |
| Drug | NSC339663 | 6.16e-11 | 250 | 33 | 9 | CID000003892 | |
| Drug | nifedipine | 2.31e-10 | 415 | 33 | 10 | CID000004485 | |
| Drug | creatine | 2.67e-10 | 193 | 33 | 8 | CID000000586 | |
| Drug | NSC107658 | 3.70e-10 | 306 | 33 | 9 | CID000002919 | |
| Drug | 4-chloroaniline | 3.84e-10 | 202 | 33 | 8 | CID000007812 | |
| Drug | trifluoperazine | 6.12e-10 | 324 | 33 | 9 | CID000005566 | |
| Drug | wartmannin | DOCK2 RAF1 MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 PIWIL2 MYH13 CDK13 | 6.86e-10 | 811 | 33 | 12 | CID000005691 |
| Drug | MgCl2 | 1.33e-09 | 354 | 33 | 9 | CID000024584 | |
| Drug | carbachol | 1.87e-09 | 688 | 33 | 11 | CID000002551 | |
| Drug | eye gene | 1.92e-09 | 369 | 33 | 9 | CID000004782 | |
| Drug | K-Cl | 4.69e-09 | 567 | 33 | 10 | CID000004873 | |
| Drug | D-triiodothyronine | 4.70e-09 | 409 | 33 | 9 | CID000000861 | |
| Drug | NSC9700 | 5.63e-09 | 578 | 33 | 10 | CID000005408 | |
| Drug | isoproterenol | 2.25e-08 | 669 | 33 | 10 | CID000003779 | |
| Drug | NSC611747 | 2.99e-08 | 352 | 33 | 8 | CID000002534 | |
| Drug | N-ethylmaleimide | 3.22e-08 | 511 | 33 | 9 | CID000004362 | |
| Drug | LY294002 | 6.44e-08 | 748 | 33 | 10 | CID000003973 | |
| Drug | pyrophosphate | 2.62e-07 | 654 | 33 | 9 | CID000001023 | |
| Drug | NSC226080 | 1.17e-06 | 782 | 33 | 9 | CID000005040 | |
| Drug | Spermine | 2.05e-06 | 63 | 33 | 4 | ctd:D013096 | |
| Drug | 4-epidoxorubicin | 1.28e-05 | 788 | 33 | 8 | CID000001690 | |
| Drug | GC 1 compound | 3.04e-05 | 6 | 33 | 2 | ctd:C413355 | |
| Drug | strontium | 1.30e-04 | 68 | 33 | 3 | CID000104798 | |
| Drug | Cefadroxil [50370-12-2]; Down 200; 11uM; HL60; HT_HG-U133A | 1.47e-04 | 186 | 33 | 4 | 1323_DN | |
| Drug | Flavonoids | 1.70e-04 | 1136 | 33 | 8 | ctd:D005419 | |
| Drug | Pantothenic acid calcium salt monohydrate [63409-48-3]; Down 200; 8uM; HL60; HT_HG-U133A | 1.83e-04 | 197 | 33 | 4 | 1311_DN | |
| Drug | Botulinum Toxins, Type A | 2.41e-04 | 16 | 33 | 2 | ctd:D019274 | |
| Drug | AC1L1CB3 | 3.07e-04 | 18 | 33 | 2 | CID000001818 | |
| Drug | CCRIS 4306 | 4.20e-04 | 21 | 33 | 2 | CID011984829 | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 4.38e-23 | 10 | 33 | 8 | DOID:0110454 (implicated_via_orthology) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 4.38e-23 | 10 | 33 | 8 | DOID:0111269 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 4.38e-23 | 10 | 33 | 8 | DOID:0080719 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 4.38e-23 | 10 | 33 | 8 | DOID:0111602 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 4.38e-23 | 10 | 33 | 8 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 4.38e-23 | 10 | 33 | 8 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 4.38e-23 | 10 | 33 | 8 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 4.38e-23 | 10 | 33 | 8 | DOID:0111596 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 4.81e-22 | 12 | 33 | 8 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 4.81e-22 | 12 | 33 | 8 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 1.25e-21 | 13 | 33 | 8 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 6.24e-21 | 15 | 33 | 8 | DOID:0050646 (implicated_via_orthology) | |
| Disease | cardiomyopathy (implicated_via_orthology) | 5.88e-17 | 71 | 33 | 9 | DOID:0050700 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 3.57e-16 | 48 | 33 | 8 | DOID:423 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 2.68e-14 | 80 | 33 | 8 | DOID:12930 (implicated_via_orthology) | |
| Disease | fish oil supplement exposure measurement, total cholesterol measurement | 1.21e-06 | 2 | 33 | 2 | EFO_0004574, EFO_0600007 | |
| Disease | Hypertrophic obstructive cardiomyopathy | 2.88e-06 | 25 | 33 | 3 | C4551472 | |
| Disease | Caveolinopathy | 7.27e-06 | 4 | 33 | 2 | cv:C5679790 | |
| Disease | fish oil supplement exposure measurement, low density lipoprotein cholesterol measurement | 7.27e-06 | 4 | 33 | 2 | EFO_0004611, EFO_0600007 | |
| Disease | CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1 | 7.27e-06 | 4 | 33 | 2 | 192600 | |
| Disease | Cardiomyopathy, Familial Hypertrophic, 1 (disorder) | 7.27e-06 | 4 | 33 | 2 | C3495498 | |
| Disease | Hypertrophic cardiomyopathy 1 | 7.27e-06 | 4 | 33 | 2 | cv:C3495498 | |
| Disease | Familial dilated cardiomyopathy | 1.64e-05 | 44 | 33 | 3 | C0340427 | |
| Disease | Cardiomyopathy, Dilated | 2.13e-05 | 48 | 33 | 3 | C0007193 | |
| Disease | Cardiomyopathy, Familial Idiopathic | 2.41e-05 | 50 | 33 | 3 | C1449563 | |
| Disease | 10-undecenoate 11:1n1 measurement | 2.54e-05 | 7 | 33 | 2 | EFO_0021099 | |
| Disease | Idiopathic hypertrophic subaortic stenosis | 2.54e-05 | 7 | 33 | 2 | C0700053 | |
| Disease | stromal cell-derived factor 1 measurement | 2.54e-05 | 7 | 33 | 2 | EFO_0020756 | |
| Disease | Obstructive asymmetric septal hypertrophy | 2.54e-05 | 7 | 33 | 2 | C0597124 | |
| Disease | Hypertrophic Cardiomyopathy | 3.58e-05 | 57 | 33 | 3 | C0007194 | |
| Disease | Distal arthrogryposis | 4.35e-05 | 9 | 33 | 2 | cv:C0265213 | |
| Disease | Cardiomyopathy, Hypertrophic, Familial | 4.35e-05 | 9 | 33 | 2 | C0949658 | |
| Disease | Muscular dystrophy, limb-girdle, autosomal dominant | 5.43e-05 | 10 | 33 | 2 | cv:C5675009 | |
| Disease | waist-hip ratio, body mass index | 7.95e-05 | 12 | 33 | 2 | EFO_0004340, EFO_0004343 | |
| Disease | Adenocarcinoma Of Esophagus | 1.09e-04 | 14 | 33 | 2 | C0279628 | |
| Disease | Primary familial hypertrophic cardiomyopathy | 2.76e-04 | 22 | 33 | 2 | cv:C0949658 | |
| Disease | Limb-girdle muscular dystrophy | 3.88e-04 | 26 | 33 | 2 | cv:C0686353 | |
| Disease | Cardiomyopathies | 4.14e-04 | 130 | 33 | 3 | C0878544 | |
| Disease | Primary familial dilated cardiomyopathy | 5.17e-04 | 30 | 33 | 2 | cv:C0340427 | |
| Disease | Heart Failure, Diastolic | 6.27e-04 | 33 | 33 | 2 | C1135196 | |
| Disease | Primary dilated cardiomyopathy | 6.65e-04 | 34 | 33 | 2 | cv:C0007193 | |
| Disease | osteoarthritis, hand | 7.88e-04 | 37 | 33 | 2 | EFO_1000789 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QIFMFLVHHSFKNAV | 876 | Q8WWZ7 | |
| MNNFLHHNDLVFKFS | 226 | Q8N1L4 | |
| KHINEHSFNNFQMKI | 1071 | O43306 | |
| NLLHNEMFILFFLLH | 216 | Q8N139 | |
| LVHFNENHIKSFMRQ | 806 | Q14004 | |
| KHLHVQETKFQMFQL | 431 | P04049 | |
| QLLFKHFSQRQEAMH | 1076 | Q14573 | |
| TNEKLQQFFNHHMFV | 481 | P12883 | |
| QQFFNHHMFVLEQEE | 486 | P12883 | |
| LDFHRMNHNQEYFEI | 536 | Q7Z6G8 | |
| FFMEQHVENVLKSHQ | 641 | O95835 | |
| EKLQQFFNHHMFVLE | 486 | P13535 | |
| FFNHHMFVLEQEEYK | 491 | P13535 | |
| EKLQQFFNHHMFVLE | 486 | Q9UKX2 | |
| FFNHHMFVLEQEEYK | 491 | Q9UKX2 | |
| VQFRQLQLFKHEMQH | 1661 | Q96RT7 | |
| EKLQQFFNHHMFVLE | 486 | P12882 | |
| FFNHHMFVLEQEEYK | 491 | P12882 | |
| MDQINHTNVKEFFFL | 1 | Q8NGJ1 | |
| FHVFDLFNKAIEMNI | 281 | Q5T6X5 | |
| TIFHLFDKQFNDHLM | 491 | O00471 | |
| MNQKFLEHTNFEFQL | 1011 | Q92608 | |
| LDVMHAIYQQNKEHF | 391 | Q8TC59 | |
| INHFNLMINKYFEDH | 261 | Q5K651 | |
| EKLQQFFNHHMFVLE | 486 | Q9Y623 | |
| FFNHHMFVLEQEEYK | 491 | Q9Y623 | |
| FTNEKLQQFFNHHMF | 481 | P11055 | |
| LQQFFNHHMFVLEQE | 486 | P11055 | |
| FTNEKLQQFFNHHMF | 481 | P13533 | |
| LQQFFNHHMFVLEQE | 486 | P13533 | |
| RLIQAAKMFFFHVQD | 11 | Q5U649 | |
| MNNFLHHNDLVFKFS | 226 | Q86W10 | |
| QHAAMFRHFQQIMFI | 136 | Q8N4C7 | |
| NFTNEKLQQFFNHHM | 481 | Q9UKX3 | |
| KLQQFFNHHMFVLEQ | 486 | Q9UKX3 | |
| HFNAHLKIADLMQFD | 196 | Q14CB8 | |
| QFTKDQMSHLFNVAH | 1931 | P27708 | |
| QKAQFTAQVHHFMEL | 21 | Q9Y5J9 | |
| NEHFSFTMLHFIKNQ | 2426 | Q9UPU5 | |
| QEANIHQFMAQFHEK | 366 | Q14139 | |
| HLDFQHSNLKQMSEF | 426 | O00206 |